MIDN and metabolic dysfunction-associated steatotic liver disease: With the help of an MIDN knocked‐out mouse model, Kweon's [16] study illustrated that MIDN attenuated the severity of nonalcoholic fatty liver disease by reducing cholesterol and lipid metabolism.